| |
| |
|
| Insider
Information: |
Treu Jesse I |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
24 |
|
| Direct
Shares |
55,258 |
|
|
Indirect Shares
|
2,983,502 |
|
|
| Direct
Value |
$34,431 |
|
|
|
Indirect Value
|
$10,546,567 |
|
|
| Total
Shares |
3,038,760 |
|
|
| Total
Value |
$10,580,997 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Nuvasive Inc |
NUVA |
10% Owner |
|
0 |
2004-05-18 |
31,204 |
Premium* |
|
|
Senomyx Inc |
SNMX |
10% Owner |
|
0 |
2004-06-25 |
19,603 |
Premium* |
|
|
Santarus Inc |
SNTS |
10% Owner |
2004-04-06 |
0 |
2004-04-06 |
64,471 |
Premium* |
|
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
Director |
2010-06-09 |
0 |
2009-12-18 |
0 |
Premium* |
|
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
2006-04-18 |
0 |
2006-12-12 |
21,068 |
Premium* |
|
|
Northstar Neuroscience Inc |
NSTR |
Director |
2007-05-18 |
17,231 |
2007-05-18 |
14,690 |
Premium* |
|
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2009-01-30 |
67,875 |
Premium* |
|
|
Volcano Corp |
VOLC |
10% Owner |
2008-04-24 |
21,289 |
2008-07-16 |
62,513 |
Premium* |
|
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
|
0 |
2014-03-19 |
0 |
Premium* |
|
|
Orexigen Therapeutics, Inc. |
OREX |
10% Owner |
2007-11-27 |
15,096 |
2011-12-22 |
50,643 |
Premium* |
|
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2010-04-27 |
0 |
2011-06-02 |
40,790 |
Premium* |
|
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
|
0 |
2013-01-18 |
244,057 |
Premium* |
|
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2010-11-29 |
0 |
2011-09-16 |
169,251 |
Premium* |
|
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
0 |
2011-11-21 |
51,013 |
Premium* |
|
|
Durata Therapeutics, Inc. |
DRTX |
10% Owner |
|
0 |
2012-07-24 |
22,306 |
Premium* |
|
|
Esperion Therapeutics, Inc. |
ESPR |
10% Owner |
|
0 |
2013-07-01 |
35,253 |
Premium* |
|
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2013-07-15 |
0 |
2013-07-15 |
1,920,730 |
Premium* |
|
|
Tobira Therapeutics Inc |
TBRA |
Director, 10% Owner |
|
0 |
2013-08-27 |
32,091 |
Premium* |
|
|
Evoke Pharma Inc |
EVOK |
10% Owner |
|
0 |
2013-09-30 |
24,256 |
Premium* |
|
|
Veracyte, Inc. |
VCYT |
Director |
2019-03-04 |
1,642 |
2019-03-04 |
1,641 |
Premium* |
|
|
Tandem Diabetes Care Inc |
TNDM |
Director, 10% Owner |
2013-11-19 |
0 |
2013-11-19 |
54,390 |
Premium* |
|
|
Dicerna Pharmaceuticals Inc |
DRNA |
10% Owner |
2014-02-04 |
0 |
2014-02-04 |
13,004 |
Premium* |
|
|
Achaogen Inc |
AKAO |
10% Owner |
2014-03-17 |
0 |
2014-03-17 |
33,890 |
Premium* |
|
|
Aldeyra Therapeutics, Inc. |
ALDX |
Director |
2019-03-26 |
0 |
2019-03-26 |
8,763 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
157 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NUVA |
Nuvasive Inc |
10% Owner |
– – • |
2004-05-12 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
8,000 |
|
- |
|
| SNMX |
Senomyx Inc |
10% Owner |
– – • |
2004-06-17 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
61,195 |
|
- |
|
| SNMX |
Senomyx Inc |
10% Owner |
– – • |
2004-06-21 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
61,195 |
|
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
officerTitle |
– • • |
2005-12-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
19,166 |
|
- |
|
| NSTR |
Northstar Neuroscience In... |
Director |
– • • |
2006-05-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
3,333 |
|
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
– – • |
2006-05-09 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
157,497 |
|
- |
|
| CADX |
Cadence Pharmaceuticals I... |
10% Owner |
– – • |
2006-10-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
27,500 |
|
- |
|
| OREX |
Orexigen Therapeutics, In... |
10% Owner |
– – • |
2007-04-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
260,000 |
|
- |
|
| ACHN |
Achillion Pharmaceuticals... |
10% Owner |
– – • |
2010-08-20 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
8,032,129 |
|
- |
|
| ZGNX |
Zogenix, Inc. |
10% Owner |
– – • |
2010-11-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
11,000 |
|
- |
|
| DRTX |
Durata Therapeutics, Inc. |
10% Owner |
– – • |
2012-07-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
6,250 |
|
- |
|
| ESPR |
Esperion Therapeutics, In... |
10% Owner |
– – • |
2013-06-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
21,471 |
|
- |
|
| OCRX |
Ocera Therapeutics Inc |
10% Owner |
– – • |
2013-07-15 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
1,588,857 |
|
- |
|
| OCRX |
Ocera Therapeutics Inc |
10% Owner |
– – • |
2013-07-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
1,629,157 |
|
- |
|
| TBRA |
Tobira Therapeutics Inc |
Director |
– • • |
2013-08-21 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
53,099 |
|
- |
|
| EVOK |
Evoke Pharma Inc |
10% Owner |
– – • |
2013-09-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
5,250 |
|
- |
|
| SNTS |
Santarus Inc |
10% Owner |
– – • |
2004-04-06 |
4 |
A |
$0.00 |
$0 |
I/I |
2,793,668 |
64,471 |
|
- |
|
| NUVA |
Nuvasive Inc |
10% Owner |
– – • |
2004-05-18 |
4 |
A |
$0.00 |
$0 |
I/I |
1,657,444 |
31,204 |
|
- |
|
| SNMX |
Senomyx Inc |
10% Owner |
– – • |
2004-06-25 |
4 |
A |
$0.00 |
$0 |
I/I |
1,490,870 |
19,603 |
|
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
officerTitle |
– • • |
2005-12-20 |
4 |
A |
$0.00 |
$0 |
I/I |
2,889,086 |
32,297 |
|
- |
|
| VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
– – • |
2006-04-18 |
4 |
A |
$0.00 |
$0 |
I/I |
3,203,594 |
33,968 |
|
- |
|
| NSTR |
Northstar Neuroscience In... |
Director |
– • • |
2006-05-10 |
4 |
A |
$0.00 |
$0 |
I/I |
2,106,086 |
37,586 |
|
- |
|
| PRTK |
Paratek Pharmaceuticals I... |
10% Owner |
– – • |
2006-05-15 |
4 |
A |
$0.00 |
$0 |
I/I |
3,731,218 |
87,424 |
|
- |
|
| VOLC |
Volcano Corp |
10% Owner |
– – • |
2006-06-20 |
4 |
A |
$0.00 |
$0 |
I/I |
9,750,411 |
132,732 |
|
- |
|
| SOMX |
Somaxon Pharmaceuticals, ... |
Director |
– • • |
2006-09-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(571,000) |
2,285,789 |
|
- |
|
157 Records found
|
|
Page 1 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
